PEDIATRICS Vol. 102 No. 1 July 1998, pp. 98-100
Received Aug 5, 1997; accepted Jan 28, 1998.
,
, ¶, and
From the Ataxia-Telangiectasia Clinical Center, the * Department
of Pediatrics, the
Department of Neurology, the § Division of
Allergy and Immunology, and the ¶ Department of Physical Medicine and
Rehabilitation at Johns Hopkins University School of Medicine, and the
Kennedy Krieger Institute, Baltimore, Maryland.
Objectives. Ataxia-telangiectasia (AT) is a rare, autosomal recessive neurodegenerative disorder in which the diagnosis is obvious when ataxia and telangiectasia are both present. However, the diagnosis can be made upon the onset of ataxia and before the appearance of telangiectasia if confirmed by laboratory tests. Early diagnosis is important for genetic counseling, appropriate care, and avoidance of unnecessary tests. The purpose of this study is to identify factors responsible for delays in the diagnosis of AT.
Design. The records of all patients seen at the Ataxia-Telangiectasia Clinical Center from July 1, 1995 to April 1, 1997 were reviewed to determine age of onset of gait abnormality, recognition of telangiectasia, and diagnosis.
Results. In 48 patients with AT, who were the index cases in their respective families, the median age of diagnosis (78 months) occurred after the onset of gait abnormalities (15 months) and closely corresponded to the development of telangiectasia (72 months). In the majority of cases (34/48), telangiectasia appeared before the diagnosis was established. The most common misdiagnosis was cerebral palsy (29/48 cases). Twenty-one children (4 with AT) were born after the start of symptoms in the index case, but before the establishment of a diagnosis.
Conclusions. The term AT, although a concise and memorable
label for the disorder, is also a barrier to early diagnosis. We recommend the use of routine serum
-fetoprotein testing for all children with persistent ataxia.
-fetoprotein,
diagnosis,
ataxia.
This article has been cited by other articles:
![]() |
Unsteady gait Postgrad. Med. J., May 1, 2006; 82(967): e8 - e8. [Full Text] [PDF] |
||||
![]() |
A. Shimamura, R. M. de Oca, J. L. Svenson, N. Haining, L. A. Moreau, D. G. Nathan, and A. D. D'Andrea A novel diagnostic screen for defects in the Fanconi anemia pathway Blood, December 15, 2002; 100(13): 4649 - 4654. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Altarescu, M. Sun, D. F. Moore, J. A. Smith, E. A. Wiggs, B. I. Solomon, N. J. Patronas, K. P. Frei, S. Gupta, C. R. Kaneski, et al. The neurogenetics of mucolipidosis type IV Neurology, August 13, 2002; 59(3): 306 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Lewis and T. O. Crawford Slow Target-Directed Eye Movements in Ataxia-Telangiectasia Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 686 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Gupta and R E Appleton Cerebral palsy: not always what it seems Arch. Dis. Child., November 1, 2001; 85(5): 356 - 360. [Full Text] [PDF] |
||||
![]() |
B. Cassinat, P. Guardiola, S. Chevret, M.-H. Schlageter, M.-E. Toubert, J.-D. Rain, and E. Gluckman Constitutive elevation of serum alpha-fetoprotein in Fanconi anemia Blood, August 1, 2000; 96(3): 859 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Hurko and T. T Provost Neurology and the skin J. Neurol. Neurosurg. Psychiatry, April 1, 1999; 66(4): 417 - 430. [Full Text] |
||||
![]() |
P. R. Borghesani, F. W. Alt, A. Bottaro, L. Davidson, S. Aksoy, G. A. Rathbun, T. M. Roberts, W. Swat, R. A. Segal, and Y. Gu From the Cover: Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice PNAS, March 28, 2000; 97(7): 3336 - 3341. [Abstract] [Full Text] [PDF] |
||||